Cardiff Oncology (CRDF) Receivables - Other (2022 - 2024)
Historic Receivables - Other for Cardiff Oncology (CRDF) over the last 3 years, with Q4 2024 value amounting to $400000.0.
- Cardiff Oncology's Receivables - Other fell 3333.33% to $400000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $400000.0, marking a year-over-year decrease of 3333.33%. This contributed to the annual value of $400000.0 for FY2024, which is 3333.33% down from last year.
- As of Q4 2024, Cardiff Oncology's Receivables - Other stood at $400000.0, which was down 3333.33% from $600000.0 recorded in Q4 2023.
- In the past 5 years, Cardiff Oncology's Receivables - Other ranged from a high of $600000.0 in Q4 2023 and a low of $400000.0 during Q4 2024
- Over the past 3 years, Cardiff Oncology's median Receivables - Other value was $500000.0 (recorded in 2022), while the average stood at $500000.0.
- Its Receivables - Other has fluctuated over the past 5 years, first surged by 2000.0% in 2023, then tumbled by 3333.33% in 2024.
- Quarter analysis of 3 years shows Cardiff Oncology's Receivables - Other stood at $500000.0 in 2022, then rose by 20.0% to $600000.0 in 2023, then crashed by 33.33% to $400000.0 in 2024.
- Its last three reported values are $400000.0 in Q4 2024, $600000.0 for Q4 2023, and $500000.0 during Q4 2022.